BMF-219

Icovamenib
DEVELOPMENT STEP phase-2
SPONSOR MATRIX Biomea Fusion [BMEA]
MECHANISM TARGET GLP1R

[THERAPEUTIC_PROFILE]

Target Indications

Type 1 / Type 2 diabetes

Mechanism Abstract

A small molecule protein degrader

[3D_INTERACTIVE_CONFORMATION]

PUBCHEM CID: 154988914
INTERACTIVE_3D_CONFORMATION
INITIALIZING_STRUCTURAL_BIOMATRIX...

[CLINICAL_TRIALS_REGISTRY]

// NO_ACTIVE_REGISTRY_STUDIES_FOUND (BMF-219)

[BIOCHEMICAL_STRUCTURE_REGISTRY]

MOLECULAR FORMULAC31H34N8O3
MOLECULAR WEIGHT566.7 g/mol
PARTITION (XLogP)N/A
H-BOND DONORS0
H-BOND ACCEPTORS0
COMPLEXITY SCOREN/A
SMILES (CANONICAL / ISOMERIC)
C=CC(=O)N[C@@H]1CCCN(C1)CC2=CC(=NC=C2)C(=O)NC3=CC=C(C=C3)C4=CC5=C(N4)N=CN=C5N6CCOCC6
INCHI KEYCPRLHPSXWZTPMC-XMMPIXPASA-N
2D_DEPICTION_FALLBACK
2D Molecular Structure Grid Layout Asset Diagram